Elfabrio Concentrate for Solution for Infusion 2 mg/ml
Product details
Registration number: SIN17186P
Classification: Prescription Only
Active ingredients: Pegunigalsidase alfa
Strength: 2 mg/ml
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: ORIENT EUROPHARMA PTE LTD
ATC code: A16AB20
HSA approval date: 20 February 2025
Manufacturer(s): Chiesi Farmaceutici S.p.A.
Manufacturing country/countries: ITALY
What are the HSA registration number and classification for Elfabrio Concentrate for Solution for Infusion 2 mg/ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17186P
Classification: Prescription Only
What active ingredients and strength are recorded for Elfabrio Concentrate for Solution for Infusion 2 mg/ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Pegunigalsidase alfa
Strength: 2 mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Elfabrio Concentrate for Solution for Infusion 2 mg/ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for Elfabrio Concentrate for Solution for Infusion 2 mg/ml?
According to the HSA dataset updated 7 August 2026:
Registrant: ORIENT EUROPHARMA PTE LTD
Which manufacturers and countries are listed for Elfabrio Concentrate for Solution for Infusion 2 mg/ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Chiesi Farmaceutici S.p.A.
Manufacturing country/countries: ITALY
Where can I look up Elfabrio Concentrate for Solution for Infusion 2 mg/ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17186P or the exact product name Elfabrio Concentrate for Solution for Infusion 2 mg/ml. The general register link does not preselect this product.
What are the source dates for this Elfabrio Concentrate for Solution for Infusion 2 mg/ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Elfabrio Concentrate for Solution for Infusion 2 mg/ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17186P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)